Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 6374907, 12 pages
https://doi.org/10.1155/2017/6374907
Research Article

Antinociceptive Activities of the Methanolic Extract of the Stem Bark of Boswellia dalzielii Hutch. (Burseraceae) in Rats Are NO/cGMP/ATP-Sensitive-K+ Channel Activation Dependent

1Department of Animal Biology, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon
2Department of Chemistry, Higher Teachers’ Training College, University of Yaoundé l, P.O. Box 47, Yaoundé, Cameroon
3Department of Chemistry, Higher Teachers’ Training College, University of Maroua, P.O. Box 55, Maroua, Cameroon

Correspondence should be addressed to Marius Mbiantcha; rf.oohay@suiramahctnaibm

Received 14 August 2017; Revised 31 October 2017; Accepted 13 November 2017; Published 6 December 2017

Academic Editor: Raffaele Capasso

Copyright © 2017 Marius Mbiantcha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. B. Nguelefack, R. C. Dutra, A. F. Paszcuk, E. L. Andrade, L. A. Tapondjou, and J. B. Calixto, “Antinociceptive activities of the methanol extract of the bulbs of Dioscorea bulbifera L. var sativa in mice is dependent of NO-cGMP-ATP-sensitive-K+ channel activation,” Journal of Ethnopharmacology, vol. 128, no. 3, pp. 567–574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. P. Cohen and J. Mao, “Neuropathic pain: mechanisms and their clinical implications,” British Medical Journal, vol. 348, Article ID f7656, 2014. View at Publisher · View at Google Scholar
  3. B. L. Emerich, R. C. M. Ferreira, M. N. Cordeiro et al., “δ-ctenitoxin-pn1a, a peptide from phoneutria nigriventer spider venom, shows antinociceptive effect involving opioid and cannabinoid systems, in rats,” Toxins, vol. 8, no. 4, article no. 106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Leadley, N. Armstrong, Y. C. Lee, A. Allen, and J. Kleijnen, “Chronic diseases in the European Union: The prevalence and health cost implications of chronic pain,” Journal of Pain and Palliative Care Pharmacotherapy, vol. 26, no. 4, pp. 310–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Torrance, B. H. Smith, M. I. Bennett, and A. J. Lee, “The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey,” The Journal of Pain, vol. 7, no. 4, pp. 281–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Bouhassira, M. Lantéri-Minet, N. Attal, B. Laurent, and C. Touboul, “Prevalence of chronic pain with neuropathic characteristics in the general population,” PAIN, vol. 136, no. 3, pp. 380–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. I. B. Walker, G. Trevisan, M. F. Rossato et al., “Antinociceptive effect of Mirabilis jalapa on acute and chronic pain models in mice,” Journal of Ethnopharmacology, vol. 149, no. 3, pp. 685–693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Katzung, S. Master, and A. Trever, Basic and Clinical Pharmacology, McGraw Hill, New York, NY, USA, 11th edition, 2009.
  9. V. Naidoo and G. E. Swan, “Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction,” Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, vol. 149, no. 3, pp. 269–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Ferreira, A. Beirith, M. A. S. Mori et al., “Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice,” The Journal of Neuroscience, vol. 25, no. 9, pp. 2405–2412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Trevisan, G. Maldaner, N. A. Velloso et al., “Antinociceptive effects of 14-membered cyclopeptide alkaloids,” Journal of Natural Products, vol. 72, no. 4, pp. 608–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Mirheydar, Herbal Information Usage of Plants in Prevention and Treatment of Diseases, Tehran University Publication, Tehran, Iran, 2003.
  13. Y. Z. Shu, “Recent natural products based drug development: a pharmaceutical industry perspective,” Journal of Natural Products, vol. 61, no. 8, pp. 1053–1071, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. B. S. da Silva, M. N. Manjavachi, A. F. Paszcuk et al., “Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models,” Neuropharmacology, vol. 62, no. 2, pp. 967–977, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. F. C. Nwinyi, L. Binda, G. A. Ajoku et al., “Evaluation of the aqueous extract of Boswellia dalzielii stem bark for antimicrobial activities and gastrointestinal effects,” African Journal of Biotechnology, vol. 3, no. 5, pp. 284–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Uzama, J. D. Gbubele, M. D. Bwai, and M. G. Kabir, “Phytochemical, Nutritional and Antimicrobial Screening of Hexane, Ethyl Acetate and Ethanolic Extracts of Boswellia Dalzielii Leaves and Bark,” American Journal of Bioscience and Bioengineering, vol. 3, no. 5, pp. 76–79, 2015. View at Google Scholar
  17. E. U. Etuk, B. M. Agaie, P. A. Onyeyili, and C. U. Ottah, “Toxicological studies of aqueous stem bark extract of Boswellia dalzielii in albino rats,” Indian Journal of Pharmacology, vol. 38, no. 5, pp. 359-360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Dimas, A. O. Ishaka, A. O. Domingo, O. O. Nureni, and A. K. Adeleke, “Constituents of the essential oils of Boswellia dalzielii Hutch from Nigeria,” Journal of Essential Oil Research, vol. 18, no. 2, pp. 119-120, 2006. View at Google Scholar
  19. H. S. Hassan, A. M. Musa, M. A. Usman, and M. Abdulaziz, “Preliminary phytochemical and antispasmodic studies of the stem bark of Boswellia dalzielii,” Nigerian Journal of Pharmaceutical Research, vol. 8, no. 1, pp. 1–6, 2009. View at Google Scholar
  20. O. B. Odeghe, D. A. Onoriose, A. A. Uwakwe, and C. C. Monago, “Hepatoprotective effect of methanolic leaf extract of Boswellia dalzielii hutch on carbon tetrachloride induced hepatotoxicity in Wistar rats,” Indian Journal of Medicine and Healthcare, vol. 1, no. 3, pp. 54–63, 2012 (Chinese). View at Google Scholar
  21. T. E. Alemika, G. O. Onawunmi, and T. O. Olugbade, “Antibacterial phenolics from Boswellia dalzielii,” Nigerian Journal of Natural Products and Medicines, vol. 10, pp. 108–110, 2006. View at Google Scholar
  22. D. D. Nando, D. Amitabh, and G. C. Young, “The anti-oxidative and anti-inflammatory roles of gallic acid on transcriptional regulation,” in Handbook on Gallic Acid, pp. 135–155, 2013. View at Google Scholar
  23. G. Trevisan, M. F. Rossato, R. Tonello et al., “Gallic acid functions as a TRPA1 antagonist with relevant antinociceptive and antiedematogenic effects in mice,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 7, pp. 679–689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. J. A. Matos, Introducão à Fitoquímica Experimental, Edicões UFC, Fortaleza, Brazil, 2nd edition, 1997.
  25. C. Pérez-Guerrero, M. D. Herrera, R. Ortiz, M. Alvarez de Sotomayor, and M. A. Fernández, “A pharmacological study of Cecropia obtusifolia Bertol aqueous extract,” Journal of Ethnopharmacology, vol. 76, no. 3, pp. 279–284, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Santos, J. B. Calixto, and G. E. P. Souza, “Effect of a kinin B 2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats,” British Journal of Pharmacology, vol. 139, no. 2, pp. 271–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Déciga-Campos, J. F. Palacios-Espinosa, A. Reyes-Ramírez, and R. Mata, “Antinociceptive and anti-inflammatory effects of compounds isolated from Scaphyglottis livida and Maxillaria densa,” Journal of Ethnopharmacology, vol. 114, no. 2, pp. 161–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C. A. L. Kassuya, J. Ferreira, R. F. Claudino, and J. B. Calixto, “Intraplantar PGE 2 causes nociceptive behaviour and mechanical allodynia: The role of prostanoid e receptors and protein kinases,” British Journal of Pharmacology, vol. 150, no. 6, pp. 727–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Kaur, H. Hamid, A. Ali, M. S. Alam, and M. Athar, “Antiinflammatory evaluation of alcoholic extract of galls of Quercus infectoria,” Journal of Ethnopharmacology, vol. 90, no. 2-3, pp. 285–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. B. Nguelefack, R. C. Dutra, A. F. Paszcuk, E. L. de Andrade, and J. B. Calixto, “TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article no. 293, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Di Martino, G. K. Campbell Jr., C. E. Wolff, and N. Hanna, “The pharmacology of arachidonic acid-induced rat paw edema,” Agents and Actions Supplements, vol. 21, no. 3-4, pp. 303-304, 1987. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Singh, D. K. Majumdar, and H. M. S. Rehan, “Evaluation of anti-inflammatory potential of fixed oil of Ocimum sanctum (Holybasil) and its possible mechanism of action,” Journal of Ethnopharmacology, vol. 54, no. 1, pp. 19–26, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Sheng, J. Shao, J. D. Morrow, R. D. Beauchamp, and R. N. DuBois, “Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells,” Cancer Research, vol. 58, no. 2, pp. 362–366, 1998. View at Google Scholar · View at Scopus
  34. Q. Xu, Y. Wang, S. Guo, Z. Shen, and L. Yang, “Anti-inflammatory and analgesic activity of aqueous extract of Flos populi,” Journal of Ethnopharmacology, vol. 152, no. 3, pp. 540–545, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Mesaik, Zaheer-Ul-Haq, S. Murad et al., “Biological and molecular docking studies on coagulin-H: Human IL-2 novel natural inhibitor,” Molecular Immunology, vol. 43, no. 11, pp. 1855–1863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Kim, M. R. Lee, G. S. Lee, W. G. An, and S. I. Cho, “Effect of Sophora flavescens Aiton extract on degranulation of mast cells and contact dermatitis induced by dinitrofluorobenzene in mice,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 253–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. D. N. Benslay and A. M. Bendele, “Development of a rapid screen for detecting and differentiating immunomodulatory vs. anti-inflammatory compounds in rats,” Agents and Actions Supplements, vol. 34, no. 1-2, pp. 254–256, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. F. C. Colpaert, T. Meert, P. de Witte, and P. Schmitt, “Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat,” Life Sciences, vol. 31, no. 1, pp. 67–75, 1982. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Medzhitov and J. Janeway C., “Advances in immunology: innate immunity,” The New England Journal of Medicine, vol. 343, no. 5, pp. 338–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. R. A. Ribeiro, M. L. Vale, S. M. Thomazzi et al., “Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice,” European Journal of Pharmacology, vol. 387, no. 1, pp. 111–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Safieh-Garabedian, S. Poole, J. J. Haddad, C. A. Massaad, S. J. Jabbur, and N. E. Saadé, “The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation,” Neuropharmacology, vol. 42, no. 6, pp. 864–872, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. T. M. Cunha, W. A. Verri, W. A. Verri Jr. et al., “TNF-α and IL-1β mediate inflammatory hypernociception in mice triggered by B 1 but not B 2 kinin receptor,” European Journal of Pharmacology, vol. 573, no. 1-3, pp. 221–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. R. R. Myers, W. M. Campana, and V. I. Shubayev, “The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets,” Drug Discovery Therapy, vol. 11, no. 1-2, pp. 8–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. H. Ferreira, “Letter to nature,” Nature New Biology, vol. 240, no. 102, pp. 200–203, 1972. View at Publisher · View at Google Scholar · View at Scopus
  45. M. S. Gold, D. B. Reichling, M. J. Shuster, and J. D. Levine, “Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 93, no. 3, pp. 1108–1112, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. J. D. England, L. T. Happel, D. G. Kline et al., “Sodium channel accumulation in humans with painful neuromas,” Neurology, vol. 47, no. 1, pp. 272–276, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. G. D. Nicol, M. R. Vasko, and A. R. Evans, “Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons,” Journal of Neurophysiology, vol. 77, no. 1, pp. 167–176, 1997. View at Google Scholar · View at Scopus
  48. A. R. Evans, M. R. Vasko, and G. D. Nicol, “The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones,” The Journal of Physiology, vol. 516, no. 1, pp. 163–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. K. C. Das and C. W. White, “Activation of NF-kappaB by antineoplastic agents: role of protein kinase C,” The Journal of Biological Chemistry, vol. 272, no. 23, pp. 14914–14920, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Muthuraman, N. Singh, and A. S. Jaggi, “Protective effect of Acorus calamus L. in rat model of vincristine induced painful neuropathy: An evidence of anti-inflammatory and anti-oxidative activity,” Food and Chemical Toxicology, vol. 49, no. 10, pp. 2557–2563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Kiguchi, T. Maeda, Y. Kobayashi, and S. Kishioka, “Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice,” Neuroscience Letters, vol. 445, no. 2, pp. 140–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Honore, D. Donnelly-Roberts, and M. T. Namovic, “A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat,” The Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 3, pp. 1376–1385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Dudhgaonkar, A. Thyagarajan, and D. Sliva, “Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum,” International Immunopharmacology, vol. 9, no. 11, pp. 1272–1280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. C. E. M. Gidding, S. J. Kellie, W. A. Kamps, and S. S. N. De Graaf, “Vincristine revisited,” Critical Review in Oncology/Hematology, vol. 29, no. 3, pp. 267–287, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. S. D. Harrison Jr., “An investigation of the mouse as a model for vincristine toxicity,” Cancer Chemotherapy and Pharmacology, vol. 11, no. 1, pp. 62–65, 1983. View at Publisher · View at Google Scholar · View at Scopus
  56. S. E. S. Nag and A. H. Katherine, “Hepatotoxicity Following Vincristine Therapy,” Cancer, vol. 54, no. 9, pp. 2006–2008, 1984. View at Google Scholar
  57. M. M. Hansen, L. Ranek, S. Walbom, and N. I. Nissen, “Fatal hepatitis following irradiation and vincristine,” Journal of Internal Medicine, vol. 212, no. 3, pp. 171–174, 1982. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Zeeyauddin, R. C. S. Setty, S. A. Majid Mufaqam, and M. Ibrahim, “Evaluation of hepatoprotective activity of Boswellia serrata leaves extracts in albino rats,” Indian Drugs, vol. 47, no. 2, pp. 19–24, 2010. View at Google Scholar · View at Scopus
  59. S. H. Ferreira and M. Nakamura, “I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process,” Prostaglandins & Other Lipid Mediators, vol. 18, no. 2, pp. 179–190, 1979. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Nakamura and S. H. Ferreira, “A peripheral sympathetic component in inflammatory hyperalgesia,” European Journal of Pharmacology, vol. 135, no. 2, pp. 145–153, 1987. View at Publisher · View at Google Scholar · View at Scopus
  61. L. M. Coussens and Z. Werb, “Inflammatory cells and cancer: think different!,” The Journal of Experimental Medicine, vol. 193, no. 6, pp. F23–F26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Nakayama, L. Yao, and G. Tosato, “Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors,” The Journal of Clinical Investigation, vol. 114, no. 9, pp. 1317–1325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  64. N. D. Goldberg, M. K. Haddox, S. E. Nicol et al., “Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis.,” Advances in Cyclic Nucleotide Research, vol. 5, pp. 307–330, 1975. View at Google Scholar · View at Scopus
  65. D. Sachs, F. Q. Cunha, and S. H. Ferreira, “Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 101, no. 10, pp. 3680–3685, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Machelska, D. Łabuz, R. Przewłocki, and B. Przewłocka, “Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord,” The Journal of Pharmacology and Experimental Therapeutics, vol. 282, no. 2, pp. 977–984, 1997. View at Google Scholar · View at Scopus
  67. H. P. Kim, K. H. Son, H. W. Chang, and S. S. Kang, “Anti-inflammatory plant flavonoids and cellular action mechanisms,” Journal of Pharmacological Sciences, vol. 96, no. 3, pp. 229–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. A. R. A. Rodrigues and I. D. G. Duarte, “The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K + channels,” British Journal of Pharmacology, vol. 129, no. 1, pp. 110–114, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. T. M. Cunha, G. R. Souza, A. C. Domingues et al., “Stimulation of peripheral Kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway,” Molecular Pain, vol. 8, article no. 10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. L. A. Tapondjou, D. Lontsi, B. L. Sondengam et al., “In vivo anti-nociceptive and anti-inflammatory effect of the two triterpenes, ursolic acid and 23-hydroxyursolic acid, from Cussonia bancoensis,” Archives of Pharmacal Research, vol. 26, no. 2, pp. 143–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. H.-J. Jung, J.-H. Nam, J. Choi, K.-T. Lee, and H.-J. Park, “19α-hydroxyursane-type triterpenoids: Antinociceptive anti-inflammatory principles of the roots of Rosa rugosa,” Biological & Pharmaceutical Bulletin, vol. 28, no. 1, pp. 101–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Qnais, K. Abu-Safieh, M. H. Abu-Dieyeh, and F. A. Abdulla, “Antinociceptive Effect of Two Flavonoids from AloysiaTriphylla L,” Jordan Journal of Biological Sciences, vol. 2, pp. 167–170, 2009. View at Google Scholar
  73. J. Narenjkar, M. Roghani, H. Alambeygi, and F. Sedaghati, “The effect of the flavonoid quercetin on pain sensation in diabetic rats,” Basic and Clinical Neuroscience, vol. 2, no. 3, pp. 51–57, 2011. View at Google Scholar · View at Scopus
  74. J. L. Maia, R. C. P. Lima-Júnior, C. M. Melo et al., “Oleanolic acid, a pentacyclic triterpene attenuates capsaicin-induced nociception in mice: Possible mechanisms,” Pharmacological Research, vol. 54, no. 4, pp. 282–286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. F. C. Meotti, A. P. Luiz, M. G. Pizzolatti, C. A. L. Kassuya, J. B. Calixto, and A. R. S. Santos, “Analysis of the antinociceptive effect of the flavonoid myricitrin: evidence for a role of the L-arginine-nitric oxide and protein kinase C pathways,” The Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 2, pp. 789–796, 2006. View at Publisher · View at Google Scholar · View at Scopus